{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:07:35Z","timestamp":1794002855496,"version":"4.8.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jtct.2024.11.003","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T17:06:10Z","timestamp":1731085570000},"page":"30.e1-30.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of ABO Mismatch and Red Blood Cell Alloimmunization on the Outcome of Hematopoietic Cell Transplantation for Sickle Cell Disease"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1957-5344","authenticated-orcid":false,"given":"Israa","family":"Saib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bader","family":"Alahmari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Alsadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0648-3256","authenticated-orcid":false,"given":"Ahmed","family":"Alaskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Hejazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hind","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Al Raiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1111-556X","authenticated-orcid":false,"given":"Abdullah S. Al","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4866-4986","authenticated-orcid":false,"given":"Ayman","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Bakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrauf","family":"Ghori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Alsuhaibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahani","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inaam","family":"Shehabeddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suha","family":"Alkhraisat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isam","family":"Mahasneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maybelle","family":"Ballili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zied","family":"Aljubour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9174-5803","authenticated-orcid":false,"given":"Mohsen","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.jtct.2024.11.003_bib0001","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jtct.2024.11.003_bib0002","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.bbmt.2015.08.036","article-title":"Nonmyeloablative stem cell transplantation with alemtuzumab\/low-dose irradiation to cure and improve the quality of life of adults with sickle cell disease","volume":"22","author":"Saraf","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"22","key":"10.1016\/j.jtct.2024.11.003_bib0003","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1182\/blood-2012-07-438408","article-title":"HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease","volume":"120","author":"Bola\u00f1os-Meade","year":"2012","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.jtct.2024.11.003_bib0004","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jama.2014.7192","article-title":"Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype","volume":"312","author":"Hsieh","year":"2014","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.jtct.2024.11.003_bib0005","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1056\/NEJMoa0904971","article-title":"Allogeneic hematopoietic stem-cell transplantation for sickle cell disease","volume":"361","author":"Hsieh","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jtct.2024.11.003_bib0006","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood.V98.6.1687","article-title":"Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation","volume":"98","author":"Bolan","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2024.11.003_bib0007","doi-asserted-by":"crossref","first-page":"e12913","DOI":"10.1111\/ctr.12913","article-title":"Higher anti-A\/B isoagglutinin titers of IgG class, but not of IgM, are associated with increased red blood cell transfusion requirements in bone marrow transplantation with major ABO-mismatch","volume":"31","author":"De Santis","year":"2017","journal-title":"Clin Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2024.11.003_bib0008","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/bmt.2011.135","article-title":"Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation","volume":"46","author":"Rowley","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2024.11.003_bib0009","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1182\/bloodadvances.2021006279","article-title":"Post-hematopoietic stem cell transplantation immune-mediated anemia: a literature review and novel therapeutics","volume":"6","author":"Migdady","year":"2022","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.jtct.2024.11.003_bib0010","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3324\/haematol.2020.270546","article-title":"Red cell transfusion and alloimmunization in sickle cell disease","volume":"106","author":"Linder","year":"2021","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.jtct.2024.11.003_bib0011","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/bjh.12061","article-title":"Challenges of alloimmunization in patients with haemoglobinopathies","volume":"159","author":"Chou","year":"2012","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.jtct.2024.11.003_bib0012","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tmrv.2018.07.003","article-title":"Impact of red blood cell antigen matching on alloimmunization and transfusion complications in patients with sickle cell disease: a systematic review","volume":"33","author":"Fasano","year":"2019","journal-title":"Transfus Med Rev"},{"issue":"11","key":"10.1016\/j.jtct.2024.11.003_bib0013","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1016\/S2352-3026(17)30196-5","article-title":"Immunohaematological complications in patients with sickle cell disease after haemopoietic progenitor cell transplantation: a prospective, single-centre, observational study","volume":"4","author":"Allen","year":"2017","journal-title":"Lancet Haematol"},{"issue":"2","key":"10.1016\/j.jtct.2024.11.003_bib0014","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41409-021-01513-5","article-title":"HLA-identical related hematopoietic stem cell transplantation in severe sickle cell disease: age is not a barrier to successful outcome","volume":"57","author":"Alzahrani","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2024.11.003_bib0015","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.bbmt.2014.11.038","article-title":"Alemtuzumab\/low dose radiation conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with sickle cell disease (SCD)","volume":"21","author":"Saraf","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2024.11.003_bib0016","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bjh.17311","article-title":"Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres","volume":"192","author":"Alzahrani","year":"2021","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.jtct.2024.11.003_bib0017","doi-asserted-by":"crossref","first-page":"e724","DOI":"10.1097\/TXD.0000000000001179","article-title":"ABO Mismatch in allogeneic hematopoietic stem cell transplant: effect on short- and long-term outcomes","volume":"7","author":"Valentini","year":"2021","journal-title":"Transplant Direct"},{"issue":"8","key":"10.1016\/j.jtct.2024.11.003_bib0018","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/TP.0b013e31824836ae","article-title":"ABO-incompatible kidney transplantation enabled by non-antigen-specific immunoadsorption","volume":"93","author":"Morath","year":"2012","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.jtct.2024.11.003_bib0019","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/TP.0b013e31819f2024","article-title":"ABO incompatible renal transplantation: a paradigm ready for broad implementation","volume":"87","author":"Montgomery","year":"2009","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.jtct.2024.11.003_bib0020","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1111\/bjh.16703","article-title":"Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation: a single-institution experience","volume":"190","author":"De Santis","year":"2020","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.jtct.2024.11.003_bib0021","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1365-2141.2009.07674.x","article-title":"Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation","volume":"145","author":"Ratanatharathorn","year":"2009","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.jtct.2024.11.003_bib0022","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bbmt.2014.12.036","article-title":"ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation","volume":"21","author":"Logan","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.11.003_bib0023","author":"Nickel","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jtct.2024.11.003_bib0024","first-page":"153","article-title":"Feasibility and safety of allogeneic hematopoietic stem cell transplantation in sickle cell disease patients with advanced kidney and liver disease. EBMT 2023 Abstract P344","volume":"58","author":"Saib","year":"2023","journal-title":"Bone Marrow Transplant."}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724007474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724007474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T03:39:45Z","timestamp":1767238785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636724007474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2666636724007474"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2024.11.003","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of ABO Mismatch and Red Blood Cell Alloimmunization on the Outcome of Hematopoietic Cell Transplantation for Sickle Cell Disease","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2024.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}